Overview

With a presence in over 80 countries, paracetamol in Panadol is one of the world’s most trusted pain relievers.^1,2

Panadol with paracetamol

Paracetamol

Globally, paracetamol or acetaminophen is one of the most used analgesic and antipyretic over-the-counter drugs.³

Multi-component paracetamol preparations

Paracetamol is currently formulated as a single compound or as an active ingredient of multi-component preparations in combination with active ingredients¹ to provide relief from fever and different types of pain (e.g. muscular and joint pains, headaches and migraines, and dysmenorrhoea).

Can be taken on an empty stomach

Paracetamol does not compromise the stomach’s protective lining and can be taken even on an empty stomach or by those at risk of stomach ulcers.^4,5*

*when used as directed

The Panadol range includes products with innovative technology for faster disintegration and absorption^5,8 and, in combination with other ingredients such as caffeine to effectively handle tough pains.^10-15

Panadol offers a range of solutions for individual patient needs

Panadol Tablets

Helps fight everyday pains and for relieving fever.

Panadol Extra

Dual “active” formulation that fights tough pains.^10-14

Panadol for children

Panadol for children contains paracetamol, which is recommended as first-line treatment for fever and mild-to-moderate pain in children.^17-19

Panadol Extend

Immediate and controlled paracetamol release for extended pain relief for up ro 8 hours.^20,21

Always follow the label prior to use

Panadol Night

Effective Solution for Night-time Pain Relief.

Panadol Ultra

Fights Pain two ways for Stronger Relief with Ibuprofen and Paracetamol.

Panadol CF

Panadol Cold & Flu provides effective relief, restores and supports your patients to recover fast from symptoms of cold, and flu.

Panadol CF Day

Panadol C&F Day provides powerful and effective Day-Time relief against cold and flu symptoms, with caffeine to produce a synergistic effect with paracetamol.^{3,4,6,8-10,18-20,34-41}

Panadol in practice

Systematic Review

Efficacy & safety of Acetaminophen and Caffeine for the management of acute dental pain.

Fever

Fever is a common sign and symptom observed in a variety of clinical settings.²⁵ Discover more about fever in adults and children including how to assess fever, “red flag” symptoms and its management.

Learn more

Headache disorders

Headache disorders, characterised by recurrent episode of headaches, are one of the most common disorders of the nervous system and, can be painful and disabling to sufferers.²⁶Find out more about tension-type headaches and migraines, “red flag” symptoms and how to manage them.

Learn more

Footnotes

*when used as directed. ^†compared to standard paracetamol tablets.

References

Glaxo Smith Kline. Available at: https://www.gsk.com/en-gb/products/our-consumer-healthcare-products/.
Prescott LF. Paracetamol: Past, present and future. Am J Ther 2000;7:143-7.
Jóźwiak-Bębenista M, Nowak JZ. Acta Pol Pharm 2014;71(1):11-23.
Graham GG, et al. Drug Saf 2005;28(3):227-40.
American College of Gastoenterology. Ulcers and gastrointestinal bleeding: protecting your health, 2016.
Wilson CG, et al. Drug Dev Ind Pharm 2011; DOI: 10.3109/03639045.2010.538058.
GlaxoSmithKline, GSK Data on File, Study A1900265.
Glaxo Smith Kline. Panadol Osteo Product Information.
Yue Y, et al. Clin Ther 2013;35(9):1306-20.
Migliardi JR, et al. Clin Pharmacol Ther 1994;56:576-86.
Ali Z, et al. Curr Med Res Opin 2007;23(4):841-51.
Rashwan WAM. J Periodontol 2009;80(6):945-52.
Pini LA, et al. J Headache Pain 2008;9:367-73.
Pini LA, et al. J Headache Pain 2012;13:669-75.
Renner B, et al. J Clin Pharmacol 2007;47:715–26.
Kelly K, et al. Pharm Res 2003;20(10):1668-73.
World Health Organization. Pocket book of hospital care for children: Guidelines for the management of common childhood illnesses, 2^nd edition. 2013.
De Martino M, Chiarugi A. Pain Ther 2015;4:149-68.
National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management, 2013. Available at: nice.org.uk/guidance/cg160. Accessed March 2019.
Dalton JT, et al. Pharm Res 2001;18:1729-34.
Bacon TH, et al. Br J Clin Pharmacol 2002;53(6):629-36.
Lipton RB, et al. Arch Neurol 1998;55:210-7.
Silberstein SD. Neurology 2000;55:754. DOI: 10.1212/WNL.55.6.754.
Glaxo Smith Kline. GSK Global Pain Index 3^rd edition, 2018.
Steele GM, et al. The Nurse Practitioner 2018;43(4):38-44.
World Health Organization. Headache disorders, 2016. Available at: https://www.who.int/news-room/fact-sheets/detail/headache-disorders.
Paracetamol-Pseudoephedrine-Ascorbic Acid GDS_v 10.0_CLEAN March 2017
Hemila H et al. Cochrane Database Syst Rev 2013; 3:CD000980.
Płusa T. Pol Merkur Lekarski 2017; 43:69–74.
Charpin J et al. Respiration 1990; 57:275–279.
Lejeune J et al. Rev Med Suisse Romande 1990; 110:181–185.
Roth RP et al. Ann Oto Rhino Laryngol 1977; 86:235-242.
Sanu A et al. Rhinology 2008; 6:271-275.
Blaiss MS et al. Curr Med Res Opin 2015; 31:1527–1538.
Brunton L et al. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12 ed. New York, NY: McGraw-Hill Medical; 2011.
Burnett I et al. Clin Ther 2006; 28:1273–1278.
Chua SS et al. Biopharm Drug Dispos 1989; 10:1–14.
Empey DW et al. Drugs 1981; 21:438–443.
Peters BH et al. Am J Med 1983; 74:36–42.
Prescott LF. Am J Ther 2000; 7:143–147.
Whelton A. Am J Ther 2005; 12:43–45.

This site is intended for Pakistan healthcare professionals only.

Sandoz Nagar, Petaro Road, Jamshoro, Sindh, 76100, Pakistan.

PM-PK-PAN-21-00019Date of Preparation: December 2021